Related Experiment Videos
Sodium-sensitive essential hypertension: emerging insights into an old entity
1Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Journal of the American College of Nutrition
|December 1, 1989
Summary
Essential hypertension is a syndrome, not a disease, with many subtypes. Salt sensitivity affects 60% of patients, with nonmodulating hypertension being a distinct entity requiring specific treatments.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Essential hypertension is increasingly viewed as a syndrome with heterogeneous causes.
- A significant subset of hypertensive individuals (approx. 60%) exhibits salt-sensitive blood pressure.
- This salt sensitivity is further divided into distinct pathophysiological entities.
Purpose of the Study:
- To explore the heterogeneity within salt-sensitive essential hypertension.
- To identify and characterize the 'nonmodulating' subtype of hypertension.
- To inform targeted therapeutic strategies based on specific pathophysiological mechanisms.
Main Methods:
- Analysis of patient subgroups within the salt-sensitive hypertensive population.
- Characterization of renovascular and adrenal responses to angiotensin II in relation to salt intake.
- Evaluation of renal blood flow, salt excretion, renin suppression, and blood pressure responses.
Main Results:
- Identified at least six major entities within salt-sensitive hypertension, including nonmodulating essential hypertension.
- Nonmodulating hypertension is characterized by a failure of renal blood flow to increase with salt loading, reduced salt excretion, and blunted renin suppression.
- These patients exhibit a hypertensive response to salt load and often have a family history of hypertension and increased erythrocyte sodium countertransport.
Conclusions:
- Essential hypertension is a syndrome with distinct salt-sensitive subgroups.
- Nonmodulating essential hypertension represents a unique pathophysiological entity.
- Understanding these specific mechanisms allows for more rational and effective therapeutic choices, potentially favoring converting enzyme inhibitors over diuretics in nonmodulators.